AstraZeneca PLC Stock Options
| AZN Stock | USD 68.36 0.17 0.25% |
AstraZeneca PLC's option chain provides insight into all available option contracts written on AstraZeneca PLC's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of AstraZeneca PLC's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given AstraZeneca option contract.
In The Money vs. Out of Money Option Contracts on AstraZeneca PLC
Analyzing AstraZeneca PLC's in-the-money options over time can help investors to take a profitable long position in AstraZeneca PLC regardless of its overall volatility. This is especially true when AstraZeneca PLC's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money AstraZeneca PLC's options could be used as guardians of the underlying stock as they move almost dollar for dollar with AstraZeneca PLC's stock while costing only a fraction of its price.
AstraZeneca PLC's latest option contracts expiring on 2024-04-19 are carrying combined implied volatility of 41.6 with a put-to-call open interest ratio of 1.08 over 90 outstanding agreements suggesting investors are buying slightly more puts than calls on contracts expiring on 2024-04-19. The current put volume is at 189, with calls trading at the volume of 490. This yields a 0.39 put-to-call volume ratio. The AstraZeneca PLC option chain provides detailed quote and price information for the current AstraZeneca PLC ADR option contracts. It shows all of AstraZeneca PLC's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-04-19 Option Contracts
AstraZeneca PLC option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in AstraZeneca PLC's lending market. For example, when AstraZeneca PLC's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on AstraZeneca PLC, he or she must hedge the risk by shorting AstraZeneca PLC stock over its option's life.
2024-04-19
The chart above shows AstraZeneca PLC's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. AstraZeneca PLC's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for AstraZeneca PLC's option, there is no secondary market available for investors to trade.
AstraZeneca PLC Maximum Pain Price across 2024-04-19 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as AstraZeneca PLC close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
AstraZeneca PLC's stock options are financial instruments that give investors the right to buy or sell shares of AstraZeneca PLC ADR common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell AstraZeneca stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If AstraZeneca PLC's stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Please note that buying 'in-the-money' options on AstraZeneca PLC lessens the impact of time decay, as they carry both intrinsic and time value. So, even if AstraZeneca PLC's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money AstraZeneca PLC contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if AstraZeneca Stock moves the wrong way.
At this time, AstraZeneca PLC's Total Stockholder Equity is very stable compared to the past year. As of the 19th of April 2024, Liabilities And Stockholders Equity is likely to grow to about 106.2 B, while Common Stock Shares Outstanding is likely to drop about 2.9 B. AstraZeneca PLC ADR In The Money Call Balance
When AstraZeneca PLC's strike price is surpassing the current stock price, the option contract against AstraZeneca PLC ADR stock is said to be in the money. When it comes to buying AstraZeneca PLC's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on AstraZeneca PLC ADR are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
AstraZeneca Current Options Market Mood
AstraZeneca PLC's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps AstraZeneca Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of AstraZeneca PLC's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. AstraZeneca PLC's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current AstraZeneca PLC's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current AstraZeneca contract
Base on the Rule 16, the options market is currently suggesting that AstraZeneca PLC ADR will have an average daily up or down price movement of about 2.6% per day over the life of the 2024-04-19 option contract. With AstraZeneca PLC trading at USD 68.36, that is roughly USD 1.78. If you think that the market is fully incorporating AstraZeneca PLC's daily price movement you should consider buying AstraZeneca PLC ADR options at the current volatility level of 41.6%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
AstraZeneca |
Purchasing AstraZeneca PLC options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" AstraZeneca calls. Remember, the seller must deliver AstraZeneca PLC ADR stock to the call owner when a call is exercised.
AstraZeneca PLC Option Chain
When AstraZeneca PLC's strike price is surpassing the current stock price, the option contract against AstraZeneca PLC ADR stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-04-192024-04-262024-05-032024-05-102024-05-172024-05-242024-05-312024-06-212024-07-192024-10-182025-01-172026-01-16
AstraZeneca PLC's option chain is a display of a range of information that helps investors for ways to trade options on AstraZeneca. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for AstraZeneca. It also shows strike prices and maturity days for a AstraZeneca PLC against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-04-19 CALL at $32.5 | 0.9897 | 0.0012 | 116 | 2024-04-19 | 34.85 - 35.95 | 33.9 | In |
Call | 2024-04-19 CALL at $35.0 | 0.9886 | 0.0014 | 58 | 2024-04-19 | 32.3 - 33.45 | 31.4 | In |
Call | 2024-04-19 CALL at $37.5 | 0.9875 | 0.0016 | 0 | 2024-04-19 | 29.85 - 30.95 | 0.0 | In |
Call | 2024-04-19 CALL at $42.5 | 0.9848 | 0.0024 | 34 | 2024-04-19 | 25.1 - 25.95 | 23.75 | In |
Call | 2024-04-19 CALL at $45.0 | 0.8944 | 0.0067 | 1 | 2024-04-19 | 21.65 - 25.0 | 23.35 | In |
Call | 2024-04-19 CALL at $47.5 | 0.9054 | 0.0078 | 0 | 2024-04-19 | 19.2 - 21.95 | 16.95 | In |
Call | 2024-04-19 CALL at $50.0 | 0.8975 | 0.0094 | 29 | 2024-04-19 | 17.3 - 19.4 | 19.7 | In |
Call | 2024-04-19 CALL at $54.0 | 0.9733 | 0.0071 | 43 | 2024-04-19 | 13.65 - 14.45 | 14.4 | In |
Call | 2024-04-19 CALL at $55.0 | 0.9924 | 0.0034 | 33 | 2024-04-19 | 13.3 - 13.45 | 12.85 | In |
Call | 2024-04-19 CALL at $56.0 | 0.9697 | 0.0092 | 0 | 2024-04-19 | 11.3 - 12.45 | 0.0 | In |
Call | 2024-04-19 CALL at $57.0 | 0.9912 | 0.0045 | 0 | 2024-04-19 | 11.3 - 11.45 | 0.0 | In |
Call | 2024-04-19 CALL at $57.5 | 0.8971 | 0.0181 | 25 | 2024-04-19 | 10.8 - 11.95 | 11.68 | In |
Call | 2024-04-19 CALL at $58.0 | 0.9905 | 0.0052 | 0 | 2024-04-19 | 10.3 - 10.45 | 0.0 | In |
Call | 2024-04-19 CALL at $59.0 | 0.8333 | 0.0219 | 61 | 2024-04-19 | 7.25 - 10.45 | 11.0 | In |
Call | 2024-04-19 CALL at $60.0 | 0.9766 | 0.0121 | 638 | 2024-04-19 | 7.35 - 9.45 | 9.6 | In |
Call | 2024-04-19 CALL at $61.0 | 0.9873 | 0.0093 | 0 | 2024-04-19 | 7.3 - 7.45 | 0.0 | In |
Call | 2024-04-19 CALL at $62.0 | 0.9857 | 0.0117 | 3 | 2024-04-19 | 6.3 - 6.45 | 4.55 | In |
Call | 2024-04-19 CALL at $62.5 | 0.9848 | 0.0134 | 1451 | 2024-04-19 | 5.8 - 5.95 | 6.29 | In |
Call | 2024-04-19 CALL at $63.0 | 0.9837 | 0.0154 | 15 | 2024-04-19 | 4.3 - 6.45 | 4.95 | In |
Call | 2024-04-19 CALL at $64.0 | 0.8247 | 0.0514 | 42 | 2024-04-19 | 3.3 - 6.4 | 4.9 | In |
Call | 2024-04-19 CALL at $65.0 | 0.9999 | 0.0273 | 7142 | 2024-04-19 | 3.3 - 3.45 | 3.36 | In |
Call | 2024-04-19 CALL at $66.0 | 0.8124 | 0.0971 | 160 | 2024-04-19 | 0.98 - 2.65 | 2.7 | In |
Call | 2024-04-19 CALL at $67.0 | 0.8796 | 0.1699 | 2612 | 2024-04-19 | 1.36 - 1.5 | 1.71 | In |
Call | 2024-04-19 CALL at $67.5 | 0.8137 | 0.2741 | 14233 | 2024-04-19 | 0.93 - 1.0 | 0.96 | In |
Call | 2024-04-19 CALL at $68.0 | 0.6565 | 0.4042 | 2531 | 2024-04-19 | 0.56 - 0.6 | 0.57 | In |
Call | 2024-04-19 CALL at $69.0 | 0.2473 | 0.3419 | 712 | 2024-04-19 | 0.11 - 0.16 | 0.18 | Out |
Call | 2024-04-19 CALL at $70.0 | 0.0493 | 0.1043 | 6715 | 2024-04-19 | 0.02 - 0.05 | 0.02 | Out |
Call | 2024-04-19 CALL at $71.0 | 0.0356 | 0.0548 | 113 | 2024-04-19 | 0.0 - 0.23 | 0.02 | Out |
Call | 2024-04-19 CALL at $72.0 | 0.0169 | 0.0252 | 248 | 2024-04-19 | 0.0 - 0.22 | 0.01 | Out |
Call | 2024-04-19 CALL at $80.0 | 0.0072 | 0.0046 | 123 | 2024-04-19 | 0.0 - 0.05 | 0.01 | Out |
Put | 2024-04-19 PUT at $55.0 | -0.0052 | 0.0025 | 329 | 2024-04-19 | 0.0 - 0.01 | 0.01 | Out |
Put | 2024-04-19 PUT at $62.5 | -0.0108 | 0.0106 | 16182 | 2024-04-19 | 0.0 - 0.02 | 0.01 | Out |
Put | 2024-04-19 PUT at $65.0 | -0.0283 | 0.0356 | 6443 | 2024-04-19 | 0.0 - 0.24 | 0.02 | Out |
Put | 2024-04-19 PUT at $66.0 | -0.0369 | 0.0597 | 3872 | 2024-04-19 | 0.0 - 0.25 | 0.02 | Out |
Put | 2024-04-19 PUT at $67.0 | -0.0983 | 0.1619 | 7129 | 2024-04-19 | 0.02 - 0.05 | 0.05 | Out |
Put | 2024-04-19 PUT at $67.5 | -0.1715 | 0.2769 | 1142 | 2024-04-19 | 0.07 - 0.1 | 0.12 | Out |
Put | 2024-04-19 PUT at $68.0 | -0.3389 | 0.4149 | 326 | 2024-04-19 | 0.18 - 0.22 | 0.26 | Out |
Put | 2024-04-19 PUT at $69.0 | -0.749 | 0.3389 | 368 | 2024-04-19 | 0.71 - 0.8 | 0.78 | In |
Put | 2024-04-19 PUT at $70.0 | -0.899 | 0.1401 | 582 | 2024-04-19 | 1.57 - 1.7 | 1.54 | In |
Put | 2024-04-19 PUT at $71.0 | -0.6141 | 0.051 | 4 | 2024-04-19 | 0.66 - 4.55 | 2.19 | In |
Put | 2024-04-19 PUT at $72.0 | -0.8827 | 0.0671 | 4 | 2024-04-19 | 2.91 - 4.7 | 5.2 | In |
Put | 2024-04-19 PUT at $72.5 | -0.7249 | 0.0534 | 0 | 2024-04-19 | 3.05 - 5.15 | 3.5 | In |
Put | 2024-04-19 PUT at $73.0 | -0.8074 | 0.0551 | 9 | 2024-04-19 | 3.55 - 6.75 | 5.15 | In |
Put | 2024-04-19 PUT at $74.0 | -0.6751 | 0.0351 | 0 | 2024-04-19 | 3.6 - 7.65 | 4.5 | In |
Put | 2024-04-19 PUT at $75.0 | -0.7641 | 0.0379 | 4 | 2024-04-19 | 5.55 - 7.7 | 5.9 | In |
Put | 2024-04-19 PUT at $76.0 | -0.7768 | 0.034 | 0 | 2024-04-19 | 6.55 - 8.7 | 6.7 | In |
Put | 2024-04-19 PUT at $77.0 | -0.8606 | 0.031 | 0 | 2024-04-19 | 8.55 - 9.7 | 7.8 | In |
Put | 2024-04-19 PUT at $77.5 | -0.7924 | 0.0296 | 0 | 2024-04-19 | 8.05 - 10.2 | 8.25 | In |
Put | 2024-04-19 PUT at $78.0 | -0.9278 | 0.0229 | 0 | 2024-04-19 | 7.9 - 11.75 | 8.8 | In |
Put | 2024-04-19 PUT at $79.0 | -0.81 | 0.0262 | 0 | 2024-04-19 | 9.55 - 11.65 | 10.45 | In |
Put | 2024-04-19 PUT at $80.0 | -0.8124 | 0.0242 | 0 | 2024-04-19 | 10.55 - 12.7 | 10.7 | In |
Put | 2024-04-19 PUT at $85.0 | -0.8998 | 0.016 | 0 | 2024-04-19 | 16.55 - 17.7 | 15.35 | In |
Put | 2024-04-19 PUT at $90.0 | -0.9122 | 0.0123 | 0 | 2024-04-19 | 21.55 - 22.7 | 20.35 | In |
Put | 2024-04-19 PUT at $95.0 | -0.8686 | 0.0119 | 0 | 2024-04-19 | 24.65 - 27.7 | 25.35 | In |
Put | 2024-04-19 PUT at $100.0 | -0.8815 | 0.0101 | 0 | 2024-04-19 | 30.35 - 32.65 | 30.35 | In |
Put | 2024-04-19 PUT at $105.0 | -0.8887 | 0.0089 | 0 | 2024-04-19 | 35.55 - 37.65 | 35.35 | In |
AstraZeneca PLC Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
AstraZeneca PLC Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
AstraZeneca Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in AstraZeneca PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
AstraZeneca PLC Corporate Directors
AstraZeneca PLC corporate directors refer to members of an AstraZeneca PLC board of directors. The board of directors generally takes responsibility for the AstraZeneca PLC's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AstraZeneca PLC's board members must vote for the resolution. The AstraZeneca PLC board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Marc Dunoyer | Chief Financial Officer, Executive Director | Profile | |
| Sherilyn McCoy | Non-Executive Independent Director | Profile | |
| Genevieve Berger | Non-Executive Independent Director | Profile | |
| Nazneen Rahman | Non-Executive Independent Director | Profile |
Already Invested in AstraZeneca PLC ADR?
The danger of trading AstraZeneca PLC ADR is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AstraZeneca PLC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AstraZeneca PLC. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AstraZeneca PLC ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.059 | Dividend Share 2.9 | Earnings Share 1.91 | Revenue Per Share 2.4547 | Quarterly Revenue Growth 0.073 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.